Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gary, Freed"'
Autor:
Harriet Hiscock, Melissa Mulraney, Daryl Efron, Gary Freed, David Coghill, Emma Sciberras, Hayley Warren, Michael Sawyer
Publikováno v:
Australian Journal of Psychology, Vol 72, Iss 1, Pp 31-40 (2020)
Objective Retrospective, parent‐reported data suggest that 50% of Australian children with mental health disorders miss out on care. In a national sample, we aimed to determine the proportion receiving mental health services and associated characte
Externí odkaz:
https://doaj.org/article/cf2d3bc33a5b4579a50f283102f1df2c
Publikováno v:
Journal of Paediatrics and Child Health. 59:487-492
Autor:
Malcolm, Risk, Salim S, Hayek, Elena, Schiopu, Liyang, Yuan, Chen, Shen, Xu, Shi, Gary, Freed, Lili, Zhao
Publikováno v:
The Lancet Rheumatology. 4:e775-e784
There is a scarcity of research regarding the effectiveness of the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in patients taking immunosuppressant medications, and no data are published to date pertaining to their effectiven
Autor:
Harriet Hiscock, Rachel O'Loughlin, Cath Laird, Rachel Pelly, Jessica Holsman, Martin Wright, Ed Oakley, Gary Freed
Publikováno v:
International Journal of Integrated Care, Vol 19, Iss 4 (2019)
Introduction: Over the past two decades, Australia’s child population has grown by 12%, yet fewer children are seen by General Practitioners (GP) (Freed, 2011) and more present to emergency departments (Freed, 2015) and hospital outpatient clinics
Externí odkaz:
https://doaj.org/article/84f1443371664afcb9d275a1bec4e956
Publikováno v:
The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 72(1)
The BNT162b2 (Pfizer-BioNTech) is approved for adolescents aged 12-17 years. We estimated BNT162b2 vaccine effectiveness (VE) and a booster dose effectiveness in adolescents aged 12-17 years and the impact of opening schools and the Omicron variant o
Autor:
Chen Shen, Malcolm Risk, Elena Schiopu, Salim S Hayek, Tiankai Xie, Lynn Holevinski, Cem Akin, Gary Freed, Lili Zhao
Publikováno v:
Ann Rheum Dis
ObjectivesWe intended to assess the effectiveness of all three US Food and Drug Administration approved COVID-19 vaccines at preventing SARS-CoV-2 infection and COVID-19 hospitalisation in a large cohort of individuals on immunosuppressants for a div
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471b8b4d97e64bf6d4d495b1ebf87c94
https://europepmc.org/articles/PMC9422955/
https://europepmc.org/articles/PMC9422955/
Autor:
Malcolm Risk, Chen Shen, Salim S Hayek, Lynn Holevinski, Elena Schiopu, Gary Freed, Cem Akin, Lili Zhao
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(1)
Background There is a lack of data regarding how the Delta variant of coronavirus disease 2019 (COVID-19) has impacted the effectiveness of the BNT162b2 (Pfizer–BioNTech), mRNA-1273 (Moderna), and Ad26.COV2.S (Johnson & Johnson–Janssen) vaccines
Publikováno v:
Critical Care Medicine. 49:19-19
Publikováno v:
Journal of paediatrics and child health. 54(6)
Publikováno v:
Australian family physician. 44(8)
A significant amount of attention has been paid to the increase in emergency department (ED) presentations in Australia. Questions have arisen regarding whether all of those presenting to the ED are actually in need of true emergency services. Under-